Many biotech companies are working on COVID-19 vaccines, but I believe BioNTech stands to be one of the biggest winners in the months ahead. More
Articles
Why a Wait-and-See Approach May Not Work With ContextLogic Stock
Investors who wait for evidence ContextLogic's turnaround is successful may find it's too late to buy WISH stock. More
Don’t Buy Skillz Until Its Revenues Catch Up to Expenses
Analysts keep lowering revenue projections for Skillz. SKLZ stock is stuck in a rut until its marketing expenses can fall below revenue. More
DraftKings Is Set to Rally as the Sports Betting Industry Booms
DKNG stock looks attractive with ample scope for organic growth. Further, the company is looking for expansion to new markets. More
Globalstar Stock Holds Growth Potential as iPhone Rumor Boost Fades
GSAT stock has slumped over 40% since the rumor of iPhone 13 satellite connectivity was proven to be wrong. More
